Format

Send to

Choose Destination
Front Immunol. 2019 Aug 30;10:2035. doi: 10.3389/fimmu.2019.02035. eCollection 2019.

Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases.

Author information

1
Genomics and Immunoregulation, Life and Medical Sciences Institute (LIMES), Bonn, Germany.
2
Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases and University of Bonn, Bonn, Germany.

Abstract

Human monocytes are divided in three major populations; classical (CD14+CD16-), non-classical (CD14dimCD16+), and intermediate (CD14+CD16+). Each of these subsets is distinguished from each other by the expression of distinct surface markers and by their functions in homeostasis and disease. In this review, we discuss the most up-to-date phenotypic classification of human monocytes that has been greatly aided by the application of novel single-cell transcriptomic and mass cytometry technologies. Furthermore, we shed light on the role of these plastic immune cells in already recognized and emerging human chronic diseases, such as obesity, atherosclerosis, chronic obstructive pulmonary disease, lung fibrosis, lung cancer, and Alzheimer's disease. Our aim is to provide an insight into the contribution of human monocytes to the progression of these diseases and highlight their candidacy as potential therapeutic cell targets.

KEYWORDS:

atherosclerosis; diet; human monocytes; neurodegeneration; respiratory diseases

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center